Compare Quest Diagnostics Inc (DGX) vs Extra Space Storage, Inc. (EXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Extra Space Storage, Inc. — how do they compare? Quest Diagnostics Inc trades at $230.89 (market cap $25.48B), while Extra Space Storage, Inc. trades at $133.94 (market cap $28.12B). The key difference: Quest Diagnostics Inc and Extra Space Storage, Inc. are close in size by market cap, and Extra Space Storage, Inc. pays the higher dividend (4.87%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Extra Space Storage, Inc. for 109 Days on average.
| DGX | EXR | |
|---|---|---|
Market Cap | $25.48B | $28.12B |
Volume | 941,866 | 2,595,579 |
Sector | Health | Real Estate |
52-Week High | $247.45 | $152.85 |
52-Week Low | $173.49 | $126.67 |
Typical Hold Time | 56 Days | 109 Days |
Enterprise Value | $31.23B | $41.84B |
Dividend Yield | 1.49% | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.
The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.
Extra Space Storage (EXR) trades at $134.22, up 1.91% today, with a bearish technical signal but strong fundamentals including a 27.79% net income margin and consistent earnings beats. The company reported $3.38B in 2025 revenue, with a P/E of 29.39 and a consensus price target of $158.33. Recent news highlights executive leadership transition and a Q3 2026 earnings call scheduled for October 27, 2026.
Outlook is mixed: analyst consensus is evenly split between Buy and Hold, with upside potential from operational strength, but risks include high debt levels and bearish technical indicators. The stock offers a dividend yield supported by stable cash flows, though macroeconomic sensitivity and valuation premiums warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →
